Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial GuidanceGlobeNewsWire • 07/28/26
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy ReachMarketBeat • 07/22/26
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation MediaGlobeNewsWire • 07/22/26
Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/04/26
Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference TranscriptSeeking Alpha • 06/03/26
Repligen Corporation to Present at William Blair 46th Annual Growth Stock ConferenceGlobeNewsWire • 05/22/26
Repligen Announces Publication of the Company's 2025 Corporate Sustainability ReportGlobeNewsWire • 05/20/26
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/12/26
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare ConferenceGlobeNewsWire • 05/07/26